Heparin Skin Necrosis: Delayed Occurrence in a Patient on Hemodialysis

American Journal of Kidney Diseases

Volumn 17, Issue 2, 1991, Pages 233-236

  Humphries, John E ^a   Kaplan, Daniel M ^a   Bolton, W Kline ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

antithrombin III; hemodialysis; heparin; Skin necrosis

Indexed keywords

HEPARIN;

ADULT; ANTITHROMBIN III DEFICIENCY; ARTICLE; CASE REPORT; COMPARATIVE STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; SKIN NECROSIS;

EID: 0025969923     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)81135-8     Document Type: Article

References (29)

1. Heparin necrosis: An anticoagulation syndrome
2. Sensitivity to intrafat heparin
3. An unusual complication of minidose heparin therapy
4. Skin necrosis after heparin injection
5. Heparin-induced skin necrosis
6. Leucocytoclastic vasculitis and skin necrosis following subcutaneous heparin calcium
7. Thrombotic complications of heparin therapy
8. Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis
9. Cutaneous heparin necrosis associated with glomerulonephritis
10. Cutaneous necrosis caused by systemically administered heparin
11. Skin necrosis due to intravenous heparin
12. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
13. Heparin-induced cutaneous necrosis unrelated to injection sites
14. Skin necrosis after heparin injection
15. Heparin-induced cutaneous necrosis in a postpartum patient
16. Heparin-associated thrombocytopenia and thrombosis
17. Coumarin necrosis associated with hereditary protein C deficiency
18. Hereditary antithrombin III (AT III) deficiency and atypical localization of a coumarin necrosis
19. Antithrombin III in patients treated with subcutaneous or intravenous heparin
20. Heparin-induced decrease in circulating antithrombin III
21. Effect of hemodialysis on protein C levels
22. Antithrombin-III and platelets in haemodialysis patients
23. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis
24. Antithrombin III is not an indicator of dialyzer biocompatibility
25. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets
26. Inhibition and complexation of activated protein C by two major inhibitors in plasma
27. Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis
28. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding
29. Hemodialysis using prostacyclin instead of heparin as the sole anti thrombotic agent